Jean François Dartigues is Professor of Public Health at the University of Bordeaux (ISPED) and Neurologist at the Institute of Neurodegenerative Diseases (Clinical part) (IMNc), CHU of Bordeaux. He has authored or co-authored over 500 professional publications in the field of epidemiology and clinical research, most of which are on Alzheimer's disease and related disorders (ADRD). (H factor=78; Source: Scopus). He is best known for his work in descriptive and analytic epidemiology of ADRD, and on prognosis and management of AD in the general population. His current research interests include the secular trends in epidemiology of ADRD, the impact of cognitive and brain reserves on cognitive decline with ageing and AD process, the evolution of dependency in ADRD and the evaluation of the impact of new structures that manage ADRD patients in France like MAIA or ESA. JF Dartigues is Director of the INSERM team “Epidemiology and Neuropsychology of Brain Ageing” from the BPH Center. He is the Principal Investigator (PI) or co-PI of three population-based cohorts on 65+ elderly subjects: Paquid since 1988, 3C study since 1999 and AMI since 2006. He is also the PI of two Multicenter Randomized Clinical Trials on non-drug treatment of ADRD : the ETNA 3 trial and the AIDALZ trial on disease management of mild AD. He was the past-Director of the « Centre de Mémoire de Ressource et de Recherche » (CMRR) of Bordeaux and founded with François Tison and Erwan Bezard the IMNc, first Clinical Center in France dedicated to Clinical research on ADRD and Parkinson’s Disease.